Building on earlier research, this study suggested a protective function of PD98059 and similarly limettin against SAD by targeting neuroinflammation caused by ERK1/2 as well as GSK-3β/ CREB/ BDNF pathway which contributes to AD etiology and progression. This evidence concerns the gene MAPK3 and Alzheimer disease.